|Articles|October 23, 2019
FDA Method for Determination of NDMA in Ranitidine
Author(s)VWR International Ltd
FDA recently posted an LC–HRMS method using the novel ACE3 C18-AR column, which can be used by regulators to detect “probable human carcinogen” NDMA in ranitidine.
Related Content
Sponsored Content
Sponsored Content
Sponsored Content
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
3
GC-MS Detection of Microbes in Spacecraft Water
4
Best of the Week: Chromatography Methods, HPLC 2026 Previews, and More
5